Abstract
Preoperative staging of extrahepatic cholangiocarcinoma is important in determining the best treatment plan. Several classification systems have been suggested to determine the operability and extent of surgery. Longitudinal tumor extent is especially important in extrahepatic cholangiocarcinoma because operative methods differ depending on the tumor extent. The Bismuth-Corlette classification system provides useful information when planning for surgery. However, this classification system is not adequate for selecting surgical candidates. Anatomic variation of the bile duct and gross morphology of the tumor must be considered simultaneously. Lateral spread of the tumor can be evaluated based on the TNM staging provided by American Joint Committee on Cancer (AJCC). However, there is a potential for ambiguity in the distinction of T1 and T2 cancer from one another. In addition, T stage does not necessarily mean invasiveness. Blumgart T staging is helpful for the assessment of resectability with the consideration of nodal status and distant metastasis as suggested by the AJCC cancer staging system. Computed tomography (CT) and magnetic resonance imaging (MRI) are the primary tools used in the assessment of longitudinal and lateral spread of a tumor when determining respectability. Diagnostic laparoscopy and positron emission tomography (PET) may play additional roles in this regard.
Similar content being viewed by others
References
Welzel TM, Graubard BI, El-Serag HB, Shaib YH, Hsing AW, Davila JA, McGlynn KA (2007) Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol 5:1221–1228
Shaib YH, El-Serag HB, Nooka AK, Thomas M, Brown TD, Patt YZ, Hassan MM (2007) Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study. Am J Gastroenterol 102:1016–1021
Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD (2005) Cholangiocarcinoma. Lancet 366:1303–1314
Lazaridis KN, Gores GJ (2005) Cholangiocarcinoma. Gastroenterology 128:1655–1667
Klatskin G (1965) Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features. Am J Med 38:241–256
Patel T (2006) Cholangiocarcinoma. Nat Clin Pract Gastroenterol Hepatol 3:33–42
Bold RJ, Goodnight JE Jr. (2004) Hilar cholangiocarcinoma: surgical and endoscopic approaches. Surg Clin North Am 84:525–542
de Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM (1999) Biliary tract cancers. N Engl J Med 341:1368–1378
Tompkins RK, Thomas D, Wile A, Longmire WP Jr. (1981) Prognostic factors in bile duct carcinoma: analysis of 96 cases. Ann Surg 194:447–457
Hong SM, Kang GH, Lee HY, Ro JY (2000) Smooth muscle distribution in the extrahepatic bile duct: histologic and immunohistochemical studies of 122 cases. Am J Surg Pathol 24:660–667
Nakeeb A, Pitt HA, Sohn TA, Coleman J, Abrams RA, Piantadosi S, Hruban RH, Lillemoe KD, Yeo CJ, Cameron JL (1996) Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 224:463–473 discussion 473–465
DeOliveira ML, Cunningham SC, Cameron JL, Kamangar F, Winter JM, Lillemoe KD, Choti MA, Yeo CJ, Schulick RD (2007) Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution. Ann Surg 245:755–762
Reding R, Buard JL, Lebeau G, Launois B (1991) Surgical management of 552 carcinomas of the extrahepatic bile ducts (gallbladder and periampullary tumors excluded). Results of the French Surgical Association Survey. Ann Surg 213:236–241
Bismuth H, Nakache R, Diamond T (1992) Management strategies in resection for hilar cholangiocarcinoma. Ann Surg 215:31–38
Madariaga JR, Iwatsuki S, Todo S, Lee RG, Irish W, Starzl TE (1998) Liver resection for hilar and peripheral cholangiocarcinomas: a study of 62 cases. Ann Surg 227:70–79
Tsao JI, Nimura Y, Kamiya J, Hayakawa N, Kondo S, Nagino M, Miyachi M, Kanai M, Uesaka K, Oda K, Rossi RL, Braasch JW, Dugan JM (2000) Management of hilar cholangiocarcinoma: comparison of an American and a Japanese experience. Ann Surg 232:166–174
Seyama Y, Makuuchi M (2007) Current surgical treatment for bile duct cancer. World J Gastroenterol 13:1505–1515
van Gulik TM, Gouma DJ (2007) Changing perspectives in the assessment of resectability of hilar cholangiocarcinoma. Ann Surg Oncol 14:1969–1971
Lee HY, Kim SH, Lee JM, Kim SW, Jang JY, Han JK, Choi BI (2006) Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT and cholangiography with revised criteria. Radiology 239:113–121
Sakamoto E, Nimura Y, Hayakawa N, Kamiya J, Kondo S, Nagino M, Kanai M, Miyachi M, Uesaka K (1998) The pattern of infiltration at the proximal border of hilar bile duct carcinoma: a histologic analysis of 62 resected cases. Ann Surg 227:405–411
Abe M, Kondo S, Hirano S, Ambo Y, Tanaka E, Saito K, Morikawa T, Okushiba S, Katoh H (2005) Superficially spreading cholangiocarcinoma. Int J Gastrointest Cancer 35:89–94
Green FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Marrow M (2002) AJCC Cancer Staging Manual. Springer, New York
Lim JH, Jang KT, Choi D, Lee WJ, Lim HK (2006) Early bile duct carcinoma: comparison of imaging features with pathologic findings. Radiology 238:542–548
Kaneko T, Nakao A, Inoue S, Harada A, Nonami T, Itoh S, Endo T, Takagi H (1995) Intraportal endovascular ultrasonography in the diagnosis of portal vein invasion by pancreatobiliary carcinoma. Ann Surg 222:711–718
Kaneko T, Nakao A, Inoue S, Endo T, Itoh S, Harada A, Nonami T, Takagi H (1994) Portal venous invasion by pancreatobiliary carcinoma: diagnosis with intraportal endovascular US. Radiology 192:681–686
Hong SM, Presley AE, Stelow EB, Frierson HF Jr., Moskaluk CA (2006) Reconsideration of the histologic definitions used in the pathologic staging of extrahepatic bile duct carcinoma. Am J Surg Pathol 30:744–749
Hong SM, Cho H, Moskaluk CA, Yu E (2007) Measurement of the invasion depth of extrahepatic bile duct carcinoma: An alternative method overcoming the current T classification problems of the AJCC staging system. Am J Surg Pathol 31:199–206
Hong SM, Kim MJ, Pi DY, Jo D, Cho HJ, Yu E, Ro JY (2005) Analysis of extrahepatic bile duct carcinomas according to the New American Joint Committee on Cancer staging system focused on tumor classification problems in 222 patients. Cancer 104:802–810
Munoz L, Roayaie S, Maman D, Fishbein T, Sheiner P, Emre S, Miller C, Schwartz ME (2002) Hilar cholangiocarcinoma involving the portal vein bifurcation: long-term results after resection. J Hepatobiliary Pancreat Surg 9:237–241
Neuhaus P, Jonas S, Bechstein WO, Lohmann R, Radke C, Kling N, Wex C, Lobeck H, Hintze R (1999) Extended resections for hilar cholangiocarcinoma. Ann Surg 230:808–818 discussion 819
Lall CG, Howard TJ, Skandarajah A, DeWitt JM, Aisen AM, Sandrasegaran K (2007) New concepts in staging and treatment of locally advanced pancreatic head cancer. AJR Am J Roentgenol 189:1044–1050
Jarnagin WR (2000) Cholangiocarcinoma of the extrahepatic bile ducts. Semin Surg Oncol 19:156–176
Nishi M, Omori Y, Miwa K (1998) Japanese Research Society for Gastric Cancer (JRSGC): Japanese classification of gastric carcinoma. Kanehara, Tokyo
Roche CJ, Hughes ML, Garvey CJ, Campbell F, White DA, Jones L, Neoptolemos JP (2003) CT and pathologic assessment of prospective nodal staging in patients with ductal adenocarcinoma of the head of the pancreas. AJR Am J Roentgenol 180:475–480
Kluge R, Schmidt F, Caca K, Barthel H, Hesse S, Georgi P, Seese A, Huster D, Berr F (2001) Positron emission tomography with [(18)F]fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer. Hepatology 33:1029–1035
Hanninen EL, Pech M, Jonas S, Ricke J, Thelen A, Langrehr J, Hintze R, Rottgen R, Denecke T, Winter L, Neuhaus P, Felix R (2005) Magnetic resonance imaging including magnetic resonance cholangiopancreatography for tumor localization and therapy planning in malignant hilar obstructions. Acta Radiol 46:462–470
Yoshida T, Matsumoto T, Sasaki A, Shibata K, Aramaki M, Kitano S (2004) Outcome of paraaortic node-positive pancreatic head and bile duct adenocarcinoma. Am J Surg 187:736–740
Shimada K, Sakamoto Y, Sano T, Kosuge T (2006) The role of paraaortic lymph node involvement on early recurrence and survival after macroscopic curative resection with extended lymphadenectomy for pancreatic carcinoma. J Am Coll Surg 203:345–352
Anderson CD, Rice MH, Pinson CW, Chapman WC, Chari RS, Delbeke D (2004) Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg 8:90–97
Kato T, Tsukamoto E, Kuge Y, Katoh C, Nambu T, Nobuta A, Kondo S, Asaka M, Tamaki N (2002) Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer. Eur J Nucl Med Mol Imaging 29:1047–1054
Goere D, Wagholikar GD, Pessaux P, Carrere N, Sibert A, Vilgrain V, Sauvanet A, Belghiti J (2006) Utility of staging laparoscopy in subsets of biliary cancers : laparoscopy is a powerful diagnostic tool in patients with intrahepatic and gallbladder carcinoma. Surg Endosc 20:721–725
Connor S, Barron E, Wigmore SJ, Madhavan KK, Parks RW, Garden OJ (2005) The utility of laparoscopic assessment in the preoperative staging of suspected hilar cholangiocarcinoma. J Gastrointest Surg 9:476–480
Jarnagin WR, Shoup M (2004) Surgical management of cholangiocarcinoma. Semin Liver Dis 24:189–199
Yeh CN, Jan YY, Chen MF (2006) Hepatectomy for peripheral cholangiocarcinoma in elderly patients. Ann Surg Oncol 13:1553–1559
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chung, Y.E., Kim, MJ., Park, Y.N. et al. Staging of extrahepatic cholangiocarcinoma. Eur Radiol 18, 2182–2195 (2008). https://doi.org/10.1007/s00330-008-1006-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-008-1006-x